Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Weighted-Average Remaining Recognition Period for by Year
Weighted-Average Remaining Recognition Period for Unrecognized SBC (years) (years)
Natera Weighted-Average Remaining Recognition Period for: 1.6 years in FY2025, unchanged from a year earlier.
Latest, FY2025
1.6
Period ended Dec 31, 2025
Change on a year earlier
0.0%
1.6 in FY2024
History
7 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K Note — Stock-Based Compensation (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-Average Remaining Recognition Period for Unrecognized SBC (years) (years) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.6 | 0.0% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 1.6 | -33.3% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 2.4 | -7.7% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 2.6 | -10.3% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 2.9 | 0.0% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 2.9 | – | Form 10-K (2021-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 2.5 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Weighted-Average Remaining Recognition Period for (years), annual FY2018–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/sbc-unrecognized-period-yrs
See every metric in the Natera KPI table. Data updated Nov 2, 2026.